About BioSapien
BioSapien is a company based in New York (United States) founded in 2018. BioSapien has raised $10.6 million across 6 funding rounds from investors including Hikma, MicroVentures and JPIN. The company has 1 employees. BioSapien offers products and services including MediChipâ„¢. BioSapien operates in a competitive market with competitors including Basilisk and Mimicrete, among others.
- Headquarter New York, United States
- Employees 1
- SectorsTechnologyHealthcare
- Website biosapien.com
- Social LinkedIn YouTube
- Legal Name Biosapien India Private Limited
- Date of Incorporation 28 Jun, 2021
- Jurisdiction Gudivada, Andhra Pradesh, India
- Total Equity Funding$10.6M (USD)
in 6 rounds
- Latest Funding Round$1.8M (USD), Seed
Jul 2025
- InvestorsHikma
& 11 more
- Employee Count1
Associated legal entities of BioSapien
BioSapien operates through Biosapien India Private Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biosapien India Private Limited CIN U85300AP2021PTC118662 | Strike Off | 28 Jun 2021 | Gudivada, Andhra Pradesh | – | – | 2 | View details |
Products & Services of BioSapien
BioSapien offers a comprehensive portfolio of products and services, including MediChip™.
Delivers targeted drugs to tumors, reducing side effects and aiding surgery.
Apps and channels of BioSapien
its YouTube channel BioSapien has 18 subscribers and 1 videos.
Videos from BioSapien
The most watched videos on BioSapien's YouTube channel, BioSapien (18 subscribers). Click a video to play it here.
More on BioSapien.
Funding Insights of BioSapien
BioSapien has successfully raised a total of $10.6M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $1.8 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.6M
- Total Rounds 6
- Last Round Seed — $1.8M
- First Round $256,000
(May 2021)
- Investors Count 12
All 6 funding rounds of BioSapien with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2025 | $1.8M | Seed | – | SOSV | |
| Jan 2025 | $1.5M | Seed | – | – | |
| Dec 2024 | $5.5M | Seed | – | Global Ventures | |
| Dec 2021 | $1.8M | Seed | – | JPIN | |
| Dec 2021 | $256,000 | Grant | – | – | |
| May 2021 | $256,000 | Grant | – | – |
12 investors in total: 11 institutional and 1 angel.
Investors in BioSapien
BioSapien has secured backing from 12 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Hikma, MicroVentures and JPIN.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in Southeast Asian startups | – | goldengate.vc | Singapore, Singapore | |
Investments are directed toward growth-stage tech firms in emerging markets. | – | global.vc | Dubai, United Arab Emirates | |
Multi sector focused full-service investment banking firm also offering VC investments | 2019 | jpin.co | London, United Kingdom | |
Venture capital and accelerator services are provided across multiple sectors. | – | sosv.com | Cork, Ireland | |
Hikma Ventures is focused on digital health investments. | 2015 | hikmaventures.com | London, United Kingdom | |
A global venture capital firm is operated to invest in innovative founders. | – | sidedoorventures.co | San Francisco, USA | |
AI, deep learning, blockchain, and automation companies receive venture capital. | – | dccapventures.com | Washington, Dc, United States | |
DARA Holdings offers comprehensive real estate investment brokerage and advisory services, specializing in sourcing, acquisition, renovation, and management of single-family and multifamily properties. | 2006 | daraholdings.com | Beverly Hills, United States | |
Equity crowdfunding is provided for startups and private markets. | 2009 | microventures.com | Austin, United States | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for BioSapien
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Biosapien India Private Limited (BioSapien)
Biosapien India Private Limited is the primary company behind BioSapien. The board of Biosapien India Private Limited currently have 2 directors; the longest-serving is Drashti Eshank Shah, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Drashti Eshank Shah DIN 08870207 | Director | 28 Jun 2021 | 5 yrs 3 mo | Biosapien India Private Limited |
| Chakka Leelaraghavajaidev DIN 07405926 | Director | 28 Jun 2021 | 5 yrs 3 mo | Biosapien India Private Limited |
People of BioSapien
2 people are tracked at BioSapien (2 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Joseph Borrello | Head Of Additive | Leadership |
Khatija Ali MD | Founder And CEO | Leadership |
Complete people profiles for BioSapien
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioSapien
3 dated milestones of BioSapien across 7 years, from founding to its latest funding, stage changes and deals.
- Founded BioSapien is founded.
- Funding First funding round of $256K.
- Funding Latest funding round, Seed, of $1.8M.
Competitors of BioSapien
BioSapien operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Basilisk and Mimicrete, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| basiliskconcrete.com | 2015 | Delft, Netherlands | – | – | Self-healing concrete mixes and repair agents are manufactured by Basilisk. | |
| mimicrete.com | 2021 | Cambridge, United States | – | 5 | Self-healing concrete mixes are manufactured for construction durability. |
Detailed competitors of BioSapien
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioSapien
The website of BioSapien (biosapien.com) receives about 1.7K visits a month.
- Monthly visits1.7K
Latest news on Biosapien
Complete news archive for BioSapien
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to BioSapien
10 companies that operate in the same segment as BioSapien (Nanotechnology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Nanotech-based electrode materials for supercapacitors are provided. | 2009 | Boston, Massachusetts, United States | USD 163.32 M | – | 66 | |
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | Menlo Park, California, United States | USD 395 M | USD 160 M | 575 | |
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
RNA therapeutics for hematology and cardiovascular diseases are developed. | 1999 | London, England, United Kingdom | – | USD 559 K | 116 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioSapien
BioSapien was founded in 2018 and raised its 1st funding round 3 years after it was founded.
BioSapien is headquartered in New York, United States. It is registered at New York, New York, United States.
BioSapien is a funded company, having raised a total of $10.6M across 6 funding rounds to date. The company's 1st funding round was a Grant of $256K, raised on May 2021.
BioSapien has 1 employees.
BioSapien developer of 3d-printed chip for cancer indications, focusing on high tech, nanotechnology, nanoenabled products, life science, drug delivery, encapsulation, and cancer treatment. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
BioSapien offers MediChipâ„¢.
BioSapien has 12 investors. Key investors include Hikma, MicroVentures, JPIN, Golden Gate Ventures, and Global Ventures.
BioSapien operates through Biosapien India Private Limited.
The legal entities of BioSapien currently have 2 directors, including Drashti Eshank Shah, Chakka Leelaraghavajaidev.